Araştırma Makalesi
BibTex RIS Kaynak Göster

REFLÜ OPERASYONU GEÇİREN HASTALARIN SES HANDİKAP İNDEKSİ ÖLÇÜMÜ

Yıl 2020, Cilt: 21 Sayı: 3, 276 - 280, 01.07.2020
https://doi.org/10.18229/kocatepetip.735941

Öz

AMAÇ: Bu çalışmada; reflü sebebiyle opere edilen hastaların ameliyat öncesi ve ameliyat sonrası 3. ay ses handikap indekslerin (SHI) karşılaştırılması amaçlanmıştır.
GEREÇ VE YÖNTEM: Reflü sebebiyle Afyonkarahisar Sağlık Bilimleri Üniversitesi Genel Cerrahi Kliniği tarafından 2014-2017 yılları arasında opere edilen 30 hastanın Afyonkarahisar Sağlık Bilimleri Üniversitesi Kulak Burun Boğaz Kliniği tarafından ameliyat öncesi ve ameliyat sonrası 3. ay ses handikap indekslerin (SHI) karşılaştırılmıştır.
BULGULAR: Çalışmaya alınan hastaların 16’sı (%53) erkek, 14’ü (%47) kadındır. Yaş ortalaması 32.45±10.16’dır Operasyon öncesi ile karşılaştırıldığında operasyon sonrasında SHI toplam skoru ile fonksiyonel, fiziksel ve emosyonel alt grup skorlarının tümünde istatistiksel olarak anlamlı iyileşme saptanmıştır.
SONUÇ: Bu çalışmada reflü cerrahisi ve ses handikap indeks skorları arasında anlamlı bir ilişki bulundu.

Kaynakça

  • 1. Chen CL, Robert JJ, Orr WC. Sleep symptoms and gastroesophageal reflux. J Clin Gastroenterol 2008;42:13-7.
  • 2. Sveen S. Symptom check: is it GERD? J Contin Educ Nurs 2009;40:103-4.
  • 3. Levine JS. Management of Barret Esophagus. Primary Care Case Reviews 2002;5:68-76.
  • 4. Hogan WJ, Shaker R. Medical treatment of supraesophageal complications of gastroesophageal reflux disease. Am J Med 2001;111:197-201.
  • 5. Castell DO, Mainie I, Tutuian R. Non-acid gastroesophageal reflux: documenting its relationship to symptoms using multichannel intraluminal impedance (MII). Trans Am Clin Climatol Assoc 2005;116:321-3.
  • 6. Bardhan KD. The role of proton pump inhibitors in the treatment of gastro-oesophageal reflux disease. Aliment Pharmacol Ther 1999;9:15-25.
  • 7. Yorulmaz İ. Larengofarengeal reflü, derleme. KBB-Forum 2002; 1(1):22-34.
  • 8. Field SK, Unxderwood M, Brant R, Cowie RL. Prevelance of gastroesophageal reflux symptoms in asthma. Chest 1996; 109: 316-22. 64
  • 9. Harding SM, Guzzo MR, Richter JE. 24-h eshophageal pH testing in asthmatics: Respiratory symptom correlation with esophageal acid events. Chest 1999; 115: 654-9.
  • 10. Irwin RS, Curley FJ, French CL. Difficult to control asthma contributing factors and outcome of a systematic management protocol. Chest 1993; 103:1662-9.
  • 11. Koufman JA. The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): A clinical investigation of 225 patients using ambulatory 24- hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury. Laryngoscope 1991;101(Suppl 53):1-78.
  • 12.Koufman JA, Amin MR, Panetti M. Prevalence of reflux in 113 consecutive patients with laryngeal and voice disorders. Otolaryngol Head Neck Surg 2000; 123:385-8.
  • 13.Ylitalo R, Lindestad P, Ramel S. Symptoms, laryngeal findings, and 24-hour pH monitoring in patients with suspected gastroesophago-pharyngeal reflux. Laryngoscope 2001; 111:1735-41.
  • 14.Oelschlager BK, Eubanks TR, Maronian N, et al. Laryngoscopy and pharyngeal pH are complementary in the diagnosis of gastroesophageallaryngeal reflux. J Gastrointest Surg 2002; 6: 189-94.
  • 15.Rouev P, Chakarski I, Doskov D, et al. Laryngopharyngeal symptoms and gastroesophageal reflux disease. J Voice 2005; 19: 476-80.
  • 16.Little FB, Koufman JA, Kohut RI, Marshall RB. Effect of gastric acid on the pathogenesis of subglottic stenosis. Ann Otol Rhinol Laryngol 1985:94:516-9.
  • 17.Book DT, Rhee JS, Toohill RJ, Smith TL. Perspectives in laryngopharyngeal reflux: An international survey. Laryngoscope 2002; 112:1399-406.
  • 18.Goldberg M, Noyek AM, Pritzker KPH. Laryngeal granuloma secondary to gastroesophageal reflux. J Otolaryngol 1978; 7: 196-202. (PMID: 691085).
  • 19.Miko TL: Peptic (contact ulcer) granuloma of the larynx. J Clin Pathol 1989; 42: 800-4. (PMID: 2768520)
  • 20.Olson NR: Laryngopharyngeal manifestations of gastroesophageal reflux disease. Otolaryngol Clin North Am 1991; 24:1201-1213. (PMID: 1754220).
  • 21. Kuhn I, Toohill RJ, Ulualp SO, Kulpa J, Hofmann C, Arndorfer R, Shaker R: Pharyngeal acid reflux events in patients with vocal cord nodules. Laryngoscope 1998; 108:1146-1149. (PMID: 9707233).
  • 22. Jindal JR, Milbrath MM, Shaker R, Hogan WJ, Toohill RJ: Gastroesophageal reflux disease as a likely cause of idiopathic subglottic stenosis. Ann Otol Rhinol Laryngol 1994; 103:186-191. (PMID: 8122834). 70
  • 23. Freije JE, Beatty TW, Campbell BH, Woodson BT, Schultz CJ, Toohill RJ: Carcinoma of the larynx in patients with gastroesophageal reflux, Am J Otolaryngol 1996; 17:386-90. (PMID: 8944297).
  • 24. Morrison MD: Is chronic gastroesophageal reflux a causative factor in glottic carcinoma? Otolaryngol Head Neck Surg 1988; 99: 370-3. (PMID: 3148885).
  • 25. Ward PH, Hanson DG: Reflux as an etiological factor of carcinoma of the laryngopharynx. Laryngoscope 1988; 98: 1195-9. (PMID: 3185074).
  • 26. Öktem F, Toprak M, Ada M, Öztürk Ö: Larenks kanseri etyolojisinde laringofaringeal reflünün yeri. Türk ORL Arşivi 2000; 38: 28-32.
  • 27. Sataloff RT, Abaza MM. İmpairment, disability and other medical-legal aspects of dysphonia. Otolaryngol Clin North Am. 2000; 33 (5): 1143-1152.
  • 28. Speyer R, Bogaarrdt HCA, Passos VL, Roodenburg NP, Zumach A, Heinen MA et al.
  • 29. Gelfer MP, Pazera JF. Maximum duration of sustained /s/ and /z/ and s/z ratio with controlled intensity. J Voice. 2006; 20: 369-79.
  • 30. Benninger MS, Ahuja AS, Gardner G, Grywalski C. Assessing outcomes for dysphonic patients. Voice. 1998; 12 (4): 540- 550.
  • 31. Jacobson BH, Johnson A, Grywasky C. The Voice Handikap Index (VHI): development and validation. J Voice. 1998; 12: 540-550.
  • 32. Mc Croy E. Voice therapy outcomes in vocal fold nodules: a retrospective audit. Int J Lang Commun Disord. 2001; 36: 19-24.
  • 33. Amir O, Tavor Y, Leibovitzh T, Ashkenazi O, Michael O, Primov-Fever A, et al. Evaluating the validity of the Voice Handicap Index-10 (VHI-10) among Hebrew speakers. Otolaryngol Head Neck Surg 2006;135:603-7.

VOICE HANDICAP INDEX MEASUREMENT OF PATIENTS WHO UNDERWENT REFLUX OPERATION

Yıl 2020, Cilt: 21 Sayı: 3, 276 - 280, 01.07.2020
https://doi.org/10.18229/kocatepetip.735941

Öz

OBJECTIVE: In this study; it was aimed to compare the voice handicap indices (VHI) of the patients who were operated for reflux to compare the preoperative and 3 months postoperative voice handicap.
MATERIAL AND METHODS: 30 patients operated by operated by Afyonkarahisar Health Sciences University General Surgery Clinic between 2014-2017 due to reflux were compared compared in terms of preoperative and postoperative 3rd month voice handicap indices (VHI) by Afyonkarahisar Health Sciences University Ear Nose Throat Clinic.
RESULTS: Sixteen (53%) of the patients included in the study were male and 14 (47%) were female. The average age is 32.45 ± 10.16. Compared with the preoperative period, there was a statistically significant improvement in VHI total score and functional, physical and emotional subgroup scores after the operation.
CONCLUSIONS: In conclusion, in this study, a significant relationship was found between reflux surgery and voice handicap index scores.

Kaynakça

  • 1. Chen CL, Robert JJ, Orr WC. Sleep symptoms and gastroesophageal reflux. J Clin Gastroenterol 2008;42:13-7.
  • 2. Sveen S. Symptom check: is it GERD? J Contin Educ Nurs 2009;40:103-4.
  • 3. Levine JS. Management of Barret Esophagus. Primary Care Case Reviews 2002;5:68-76.
  • 4. Hogan WJ, Shaker R. Medical treatment of supraesophageal complications of gastroesophageal reflux disease. Am J Med 2001;111:197-201.
  • 5. Castell DO, Mainie I, Tutuian R. Non-acid gastroesophageal reflux: documenting its relationship to symptoms using multichannel intraluminal impedance (MII). Trans Am Clin Climatol Assoc 2005;116:321-3.
  • 6. Bardhan KD. The role of proton pump inhibitors in the treatment of gastro-oesophageal reflux disease. Aliment Pharmacol Ther 1999;9:15-25.
  • 7. Yorulmaz İ. Larengofarengeal reflü, derleme. KBB-Forum 2002; 1(1):22-34.
  • 8. Field SK, Unxderwood M, Brant R, Cowie RL. Prevelance of gastroesophageal reflux symptoms in asthma. Chest 1996; 109: 316-22. 64
  • 9. Harding SM, Guzzo MR, Richter JE. 24-h eshophageal pH testing in asthmatics: Respiratory symptom correlation with esophageal acid events. Chest 1999; 115: 654-9.
  • 10. Irwin RS, Curley FJ, French CL. Difficult to control asthma contributing factors and outcome of a systematic management protocol. Chest 1993; 103:1662-9.
  • 11. Koufman JA. The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): A clinical investigation of 225 patients using ambulatory 24- hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury. Laryngoscope 1991;101(Suppl 53):1-78.
  • 12.Koufman JA, Amin MR, Panetti M. Prevalence of reflux in 113 consecutive patients with laryngeal and voice disorders. Otolaryngol Head Neck Surg 2000; 123:385-8.
  • 13.Ylitalo R, Lindestad P, Ramel S. Symptoms, laryngeal findings, and 24-hour pH monitoring in patients with suspected gastroesophago-pharyngeal reflux. Laryngoscope 2001; 111:1735-41.
  • 14.Oelschlager BK, Eubanks TR, Maronian N, et al. Laryngoscopy and pharyngeal pH are complementary in the diagnosis of gastroesophageallaryngeal reflux. J Gastrointest Surg 2002; 6: 189-94.
  • 15.Rouev P, Chakarski I, Doskov D, et al. Laryngopharyngeal symptoms and gastroesophageal reflux disease. J Voice 2005; 19: 476-80.
  • 16.Little FB, Koufman JA, Kohut RI, Marshall RB. Effect of gastric acid on the pathogenesis of subglottic stenosis. Ann Otol Rhinol Laryngol 1985:94:516-9.
  • 17.Book DT, Rhee JS, Toohill RJ, Smith TL. Perspectives in laryngopharyngeal reflux: An international survey. Laryngoscope 2002; 112:1399-406.
  • 18.Goldberg M, Noyek AM, Pritzker KPH. Laryngeal granuloma secondary to gastroesophageal reflux. J Otolaryngol 1978; 7: 196-202. (PMID: 691085).
  • 19.Miko TL: Peptic (contact ulcer) granuloma of the larynx. J Clin Pathol 1989; 42: 800-4. (PMID: 2768520)
  • 20.Olson NR: Laryngopharyngeal manifestations of gastroesophageal reflux disease. Otolaryngol Clin North Am 1991; 24:1201-1213. (PMID: 1754220).
  • 21. Kuhn I, Toohill RJ, Ulualp SO, Kulpa J, Hofmann C, Arndorfer R, Shaker R: Pharyngeal acid reflux events in patients with vocal cord nodules. Laryngoscope 1998; 108:1146-1149. (PMID: 9707233).
  • 22. Jindal JR, Milbrath MM, Shaker R, Hogan WJ, Toohill RJ: Gastroesophageal reflux disease as a likely cause of idiopathic subglottic stenosis. Ann Otol Rhinol Laryngol 1994; 103:186-191. (PMID: 8122834). 70
  • 23. Freije JE, Beatty TW, Campbell BH, Woodson BT, Schultz CJ, Toohill RJ: Carcinoma of the larynx in patients with gastroesophageal reflux, Am J Otolaryngol 1996; 17:386-90. (PMID: 8944297).
  • 24. Morrison MD: Is chronic gastroesophageal reflux a causative factor in glottic carcinoma? Otolaryngol Head Neck Surg 1988; 99: 370-3. (PMID: 3148885).
  • 25. Ward PH, Hanson DG: Reflux as an etiological factor of carcinoma of the laryngopharynx. Laryngoscope 1988; 98: 1195-9. (PMID: 3185074).
  • 26. Öktem F, Toprak M, Ada M, Öztürk Ö: Larenks kanseri etyolojisinde laringofaringeal reflünün yeri. Türk ORL Arşivi 2000; 38: 28-32.
  • 27. Sataloff RT, Abaza MM. İmpairment, disability and other medical-legal aspects of dysphonia. Otolaryngol Clin North Am. 2000; 33 (5): 1143-1152.
  • 28. Speyer R, Bogaarrdt HCA, Passos VL, Roodenburg NP, Zumach A, Heinen MA et al.
  • 29. Gelfer MP, Pazera JF. Maximum duration of sustained /s/ and /z/ and s/z ratio with controlled intensity. J Voice. 2006; 20: 369-79.
  • 30. Benninger MS, Ahuja AS, Gardner G, Grywalski C. Assessing outcomes for dysphonic patients. Voice. 1998; 12 (4): 540- 550.
  • 31. Jacobson BH, Johnson A, Grywasky C. The Voice Handikap Index (VHI): development and validation. J Voice. 1998; 12: 540-550.
  • 32. Mc Croy E. Voice therapy outcomes in vocal fold nodules: a retrospective audit. Int J Lang Commun Disord. 2001; 36: 19-24.
  • 33. Amir O, Tavor Y, Leibovitzh T, Ashkenazi O, Michael O, Primov-Fever A, et al. Evaluating the validity of the Voice Handicap Index-10 (VHI-10) among Hebrew speakers. Otolaryngol Head Neck Surg 2006;135:603-7.
Toplam 33 adet kaynakça vardır.

Ayrıntılar

Birincil Dil Türkçe
Konular Klinik Tıp Bilimleri
Bölüm Makaleler-Araştırma Yazıları
Yazarlar

Şahin Ulu 0000-0002-5462-9520

Murat Akıcı 0000-0001-6739-0670

Mümtaz Erakın 0000-0001-9558-6005

Selçuk Kuzu 0000-0002-0511-9874

Yayımlanma Tarihi 1 Temmuz 2020
Kabul Tarihi 5 Haziran 2020
Yayımlandığı Sayı Yıl 2020 Cilt: 21 Sayı: 3

Kaynak Göster

APA Ulu, Ş., Akıcı, M., Erakın, M., Kuzu, S. (2020). REFLÜ OPERASYONU GEÇİREN HASTALARIN SES HANDİKAP İNDEKSİ ÖLÇÜMÜ. Kocatepe Tıp Dergisi, 21(3), 276-280. https://doi.org/10.18229/kocatepetip.735941
AMA Ulu Ş, Akıcı M, Erakın M, Kuzu S. REFLÜ OPERASYONU GEÇİREN HASTALARIN SES HANDİKAP İNDEKSİ ÖLÇÜMÜ. KTD. Temmuz 2020;21(3):276-280. doi:10.18229/kocatepetip.735941
Chicago Ulu, Şahin, Murat Akıcı, Mümtaz Erakın, ve Selçuk Kuzu. “REFLÜ OPERASYONU GEÇİREN HASTALARIN SES HANDİKAP İNDEKSİ ÖLÇÜMÜ”. Kocatepe Tıp Dergisi 21, sy. 3 (Temmuz 2020): 276-80. https://doi.org/10.18229/kocatepetip.735941.
EndNote Ulu Ş, Akıcı M, Erakın M, Kuzu S (01 Temmuz 2020) REFLÜ OPERASYONU GEÇİREN HASTALARIN SES HANDİKAP İNDEKSİ ÖLÇÜMÜ. Kocatepe Tıp Dergisi 21 3 276–280.
IEEE Ş. Ulu, M. Akıcı, M. Erakın, ve S. Kuzu, “REFLÜ OPERASYONU GEÇİREN HASTALARIN SES HANDİKAP İNDEKSİ ÖLÇÜMÜ”, KTD, c. 21, sy. 3, ss. 276–280, 2020, doi: 10.18229/kocatepetip.735941.
ISNAD Ulu, Şahin vd. “REFLÜ OPERASYONU GEÇİREN HASTALARIN SES HANDİKAP İNDEKSİ ÖLÇÜMÜ”. Kocatepe Tıp Dergisi 21/3 (Temmuz 2020), 276-280. https://doi.org/10.18229/kocatepetip.735941.
JAMA Ulu Ş, Akıcı M, Erakın M, Kuzu S. REFLÜ OPERASYONU GEÇİREN HASTALARIN SES HANDİKAP İNDEKSİ ÖLÇÜMÜ. KTD. 2020;21:276–280.
MLA Ulu, Şahin vd. “REFLÜ OPERASYONU GEÇİREN HASTALARIN SES HANDİKAP İNDEKSİ ÖLÇÜMÜ”. Kocatepe Tıp Dergisi, c. 21, sy. 3, 2020, ss. 276-80, doi:10.18229/kocatepetip.735941.
Vancouver Ulu Ş, Akıcı M, Erakın M, Kuzu S. REFLÜ OPERASYONU GEÇİREN HASTALARIN SES HANDİKAP İNDEKSİ ÖLÇÜMÜ. KTD. 2020;21(3):276-80.

88x31.png
Bu Dergi Creative Commons Atıf-GayriTicari-AynıLisanslaPaylaş 4.0 Uluslararası Lisansı ile lisanslanmıştır.